181 related articles for article (PubMed ID: 33976278)
1. Acute toxicity analysis of an inhibitor of BCL2, Disarib, in rats.
Sharma S; Varsha KK; Ray U; Siddiqua H; Jose AE; Muninarasimaiah S; Raghavan SC; Choudhary B
Sci Rep; 2021 May; 11(1):9982. PubMed ID: 33976278
[TBL] [Abstract][Full Text] [Related]
2. A novel inhibitor of BCL2, Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosis.
Vartak SV; Hegde M; Iyer D; Gaikwad S; Gopalakrishnan V; Srivastava M; Karki SS; Choudhary B; Ray P; Santhoshkumar TR; Raghavan SC
Biochem Pharmacol; 2016 Dec; 122():10-22. PubMed ID: 27693384
[TBL] [Abstract][Full Text] [Related]
3. Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction.
Vartak SV; Iyer D; Santhoshkumar TR; Sharma S; Mishra A; Goldsmith G; Srivastava M; Srivastava S; Karki SS; Surolia A; Choudhary B; Raghavan SC
Biochem Pharmacol; 2017 May; 131():16-28. PubMed ID: 28223017
[TBL] [Abstract][Full Text] [Related]
4. Acute toxicity analysis of Disarib, an inhibitor of BCL2.
Sharma S; Varsha KK; Kumari S; Gopalakrishnan V; Jose AE; Choudhary B; Mantelingu K; Raghavan SC
Sci Rep; 2020 Sep; 10(1):15188. PubMed ID: 32938954
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain.
Iyer D; Vartak SV; Mishra A; Goldsmith G; Kumar S; Srivastava M; Hegde M; Gopalakrishnan V; Glenn M; Velusamy M; Choudhary B; Kalakonda N; Karki SS; Surolia A; Raghavan SC
FEBS J; 2016 Sep; 283(18):3408-37. PubMed ID: 27444341
[TBL] [Abstract][Full Text] [Related]
6. Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor.
Manjunath M; Swaroop S; Pradhan SS; Rao K R; Mahadeva R; Sivaramakrishnan V; Choudhary B
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35885991
[TBL] [Abstract][Full Text] [Related]
7. Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential.
Joy R; Siddiqua H; Sharma S; Raveendran M; John F; Hassan PA; Gawali SL; Raghavan SC; George J
ACS Omega; 2023 Oct; 8(43):40729-40740. PubMed ID: 37929147
[TBL] [Abstract][Full Text] [Related]
8. A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.
Ramsey HE; Fischer MA; Lee T; Gorska AE; Arrate MP; Fuller L; Boyd KL; Strickland SA; Sensintaffar J; Hogdal LJ; Ayers GD; Olejniczak ET; Fesik SW; Savona MR
Cancer Discov; 2018 Dec; 8(12):1566-1581. PubMed ID: 30185627
[TBL] [Abstract][Full Text] [Related]
9. Resistance to apoptosis and autophagy leads to enhanced survival in Sertoli cells.
Aslani F; Sebastian T; Keidel M; Fröhlich S; Elsässer HP; Schuppe HC; Klug J; Mahavadi P; Fijak M; Bergmann M; Meinhardt A; Bhushan S
Mol Hum Reprod; 2017 Jun; 23(6):370-380. PubMed ID: 28379541
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming cell death: BCL2 family inhibition in hematological malignancies.
Scarfò L; Ghia P
Immunol Lett; 2013; 155(1-2):36-9. PubMed ID: 24095849
[TBL] [Abstract][Full Text] [Related]
11. Acute oral toxicity study of magnesium oxide nanoparticles and microparticles in female albino Wistar rats.
Mangalampalli B; Dumala N; Grover P
Regul Toxicol Pharmacol; 2017 Nov; 90():170-184. PubMed ID: 28899817
[TBL] [Abstract][Full Text] [Related]
12. Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators.
Lotfy G; Abdel Aziz YM; Said MM; El Ashry ESH; El Tamany ESH; Abu-Serie MM; Teleb M; Dömling A; Barakat A
Bioorg Chem; 2021 Dec; 117():105427. PubMed ID: 34794098
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of curcumin and silymarin against paracetamol induced hepatotoxicity in adult male albino rats.
Ahmad MM; Rezk NA; Fawzy A; Sabry M
Gene; 2019 Sep; 712():143966. PubMed ID: 31279711
[TBL] [Abstract][Full Text] [Related]
14. BCL2: A promising cancer therapeutic target.
Radha G; Raghavan SC
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):309-314. PubMed ID: 28647470
[TBL] [Abstract][Full Text] [Related]
15. Toxicity assessment of manganese oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral exposure.
Singh SP; Kumari M; Kumari SI; Rahman MF; Mahboob M; Grover P
J Appl Toxicol; 2013 Oct; 33(10):1165-79. PubMed ID: 23702825
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol induces the antiapoptotic proteins Nrf
Ahmed SA; Mohammed WI
Biomed Pharmacother; 2021 Jul; 139():111594. PubMed ID: 33878623
[TBL] [Abstract][Full Text] [Related]
17. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.
Dharap SS; Chandna P; Wang Y; Khandare JJ; Qiu B; Stein S; Minko T
J Pharmacol Exp Ther; 2006 Mar; 316(3):992-8. PubMed ID: 16291730
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.
Han B; Park D; Li R; Xie M; Owonikoko TK; Zhang G; Sica GL; Ding C; Zhou J; Magis AT; Chen ZG; Shin DM; Ramalingam SS; Khuri FR; Curran WJ; Deng X
Cancer Cell; 2015 Jun; 27(6):852-63. PubMed ID: 26004684
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity and acute and subchronic toxicity studies of a bioactive polyoxometalate in Wistar rats.
Qu X; Xu K; Zhao C; Song X; Li J; Li L; Nie W; Bao H; Wang J; Niu F; Li J
BMC Pharmacol Toxicol; 2017 Apr; 18(1):26. PubMed ID: 28381296
[TBL] [Abstract][Full Text] [Related]
20. Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
Dunham D; Viswanathan P; Gill J; Manzano M
J Virol; 2022 Dec; 96(23):e0136022. PubMed ID: 36416587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
